Center for Cancer Immunotherapy and Immunobiology

Preview: IASLC | ASCO 2025 North American Conference on Lung Cancer | IASLC Join Dr. Stephen Liu on Lung Cancer Considered as he sits down with two co-chairs of the upcoming IASLC | ASCO 2025 North American Conference on Lung Cancer (NA ...

#NACLC25 is open! Registration & abstracts are live for Dec 5–7, 2025, in Chicago.

Hear from co‑chairs @kamarronemd.bsky.social & Ramesh Rengan, MD, PhD, FASTRO on Lung Cancer Considered—insights, highlights & why you should be there.

🎧 bit.ly/NACLC25Preview

#LungCancer @ascocancer.bsky.social

Center for Cancer Immunotherapy and Immunobiology 京都大学大学院医学研究科附属 がん免疫総合研究センター（Center for Cancer Immunotherapy and Immunobiology（CCII））は、2020年4月1日に開設されました。 このセンターでは、「がんの征圧」という大きな夢に向かって集う世界各国から集まった研究者が活発な研究を行います。

The Center for Cancer #Immunotherapy & Immunobiology at Kyoto University is headed by Prof. Tasuku Honjo, our founding Director, and vice Director Sidonia Fagarasan.

Visit our site to learn about our research, events, news, & opportunities at CCII.
#Immunology
www.ccii.med.kyoto-u.ac.jp/en/

Kinase gene alterations in cancer

For readers interested in anticancer drugs, this Review in the July issue discusses progress and challenges in the development of tumour-agnostic kinase inhibitors
www.nature.com/articles/s41...
rdcu.be/eybm4

Vice director Sidonia Fagarasan introducing Jianguo (Jeff) Xia from McGill University, who gave a seminar on "Leveraging #metabolomics and biological networks for functional insights into microbiome” this week at CCII.
www.ccii.med.kyoto-u.ac.jp/en/event/eve...

ICYMI

ICYMI

An unforgettable week of science and collaboration in Kyoto! 🔬 A huge thank you to the brilliant Sidonia Făgărășan and her entire lab for hosting me at the Center for Cancer Immunotherapy and Immunobiology (CCII).

Looking forward to future collaborations!

Jianguo (Jeff) Xia Image by Alex Tran. Professor - Large Data Analysis Canada Research Chair (Tier 2) Bioinformatics and Big Data Analytics (Cross-appointed with the Department of Animal Science) T: 514-398-8668 |...

Dr Xia's lab at McGill works on "understanding important biological, environmental and nutritional factors on health and disease; developing computational solutions for high-throughput experiments."
www.mcgill.ca/parasitology...

Vice director Sidonia Fagarasan introducing Jianguo (Jeff) Xia from McGill University, who gave a seminar on "Leveraging #metabolomics and biological networks for functional insights into microbiome” this week at CCII.
www.ccii.med.kyoto-u.ac.jp/en/event/eve...

1 month to abstract deadline for the first cell biology of the nucleus meeting at @embl.org in many years - organised by the stellar @luskinglab.bsky.social @sarawickstrom.bsky.social Tom Quail & Simone Koehler

Tons of open slots, invited and selected speakers all get 20 mins ❤️

#EESNucleus

These are extremely challenging times for early-career faculty. Here is my office's small contribution to make their hard and important work a bit easier:

Download our curated and comprehensive database of funding opportunities for early-career faculty.

Here: research.jhu.edu/rdt/funding-...

🔊2025/2026 EMBO Courses & Workshops are online!
You can go through the list here ➡️ www.embo.org/conferences-...
Download the poster listing all meetings here ➡️ www.embo.org/documents/co...
We will add more 2026 Courses & Workshops in October, stay tuned!
#EMBOevents #AcademicSky #LifeSciences

Cancer vaccines and the future of immunotherapy Vaccines have had a major impact on the control of infectious disease, most recently by helping to combat the COVID-19 pandemic. Prophylactic cancer vaccines have prevented several malignancies by pro...

🗨️ “Vaccines have done more to improve public health than any other medical intervention.”

A Viewpoint focuses on cancer vaccines & the future of immunotherapy—analysing trials & how the next generation of cancer vaccines can help improve patient outcomes & quality of life. tinyurl.com/n94jsbju

How a bacterial strain from patients who responded to immunotherapy, when transferred to mice, revved up the immune response vs. tumors
www.nature.com/articles/s41...

The Junior PI call @ccii-kyoto.bsky.social is open until the end of the month.
Join us in Kyoto! 👇
#Immunology #Immunotherapy #Immunosky

At @ccii-kyoto.bsky.social Dr Nishikawa heads the Division of Cancer Immune Multicellular System Regulation

www.ccii.med.kyoto-u.ac.jp/en/research/...

Microbiota-driven antitumour immunity mediated by dendritic cell migration - Nature A newly identified bacterial strain (YB328) isolated from the faeces of patients who responded to immune checkpoint blockade therapies can promote antitumour immunity through the activation of tumour-...

CCII/National Cancer Center researcher Hiroyoshi Nishikawa & collaborators isolated a novel bacterial strain which may enhance immunotherapy efficacy by stimulating gut DCs to migrate & activate CD8 cells in the TME

#Immunology #Immunotherapy

www.nature.com/articles/s41...

The Junior PI call @ccii-kyoto.bsky.social is open until the end of the month.
Join us in Kyoto! 👇
#Immunology #Immunotherapy #Immunosky

Cancer progression through the lens of age-induced metabolic reprogramming - Nature Reviews Cancer In this Perspective, Lazure and Gomes argue that metabolic changes that occur as a result of ageing may shape tumour initiation and progression and the development of metastatic disease.

#Perspective 🚨
Lazure and Gomes argue that metabolic changes that occur as a result of #ageing may shape tumour initiation and progression and the development of metastatic disease.
⬇️ 📖
https://bit.ly/3IkNY...
@moffittnews.bsky.social‬

Meet the moment & help shape the future of GI cancer care by submitting an abstract to #GI26. Whether you have a study in progress or late-stage clinical trial, this meeting offers oral & poster presentation opportunities across all disciplines & GI disease sites.

Submit today: brnw.ch/21wUg0p

Have you nominated a colleague for the Pezcoller-Marina Larcher Fogazzaro-EACR Women in Cancer Research Award yet? 🏆

All that's needed is a few details and a letter of support, and anyone can make a nomination.

Don't miss the 12 September deadline: eacr.org/pezcoller-fo...

At @ccii-kyoto.bsky.social Dr Nishikawa heads the Division of Cancer Immune Multicellular System Regulation

www.ccii.med.kyoto-u.ac.jp/en/research/...

Microbiota-driven antitumour immunity mediated by dendritic cell migration - Nature A newly identified bacterial strain (YB328) isolated from the faeces of patients who responded to immune checkpoint blockade therapies can promote antitumour immunity through the activation of tumour-...

CCII/National Cancer Center researcher Hiroyoshi Nishikawa & collaborators isolated a novel bacterial strain which may enhance immunotherapy efficacy by stimulating gut DCs to migrate & activate CD8 cells in the TME

#Immunology #Immunotherapy

www.nature.com/articles/s41...

The Fagarasan Lab at CCII studies higher order regulation of immune responses, including the effects of metabolism and the nervous system in anti-tumor immunity
#Immunology #Immunotherapy #Metabolism

www.ccii.med.kyoto-u.ac.jp/en/research/...

CCII's Vice Director, Sidonia Fagarasan, and the faculty of this year's RIKEN IMS-JSI Summer School & Symposium.
Sidonia spoke about the biochemical dialog between immune cells mediating anti-cancer responses
www.ims.riken.jp/events/rcais...

Our Junior PI call is open until the end of the month
#ScienceJobs #Immunojobs #Immunology #Immunotherapy

ICYMI: Junior PI positions in Kyoto at @ccii-kyoto.bsky.social, a new center led by Tasuku Honjo (DIrector) & Sidonia Fagarasan (Vice Director)
#Immunology #Immunotherapy #ScienceJobs

🎧 New podcast episode! Listen to 'Ask me anything about... the science of cancer-associated cachexia' ➡️️ zurl.co/lDcME 

Experts from the Cancer Cachexia Action Network unpack the topic with @crukcampanccan.bsky.social.

@cam.ac.uk @cruk-si.bsky.social @cshlnews.bsky.social

Ready to explore what's next in the life sciences? 🧬🔍 Then check out our new 2026 EMBL Annual Poster 👉 s.embl.org/2026-poster

Join us for another year of asking the big questions in the life sciences. See you in 2026?

#EMBL #lifesciences #molecularbiology #bioinformatics

The Fagarasan Lab at CCII studies higher order regulation of immune responses, including the effects of metabolism and the nervous system in anti-tumor immunity
#Immunology #Immunotherapy #Metabolism

www.ccii.med.kyoto-u.ac.jp/en/research/...